Sulfasalazine
Sulfasalazine is a pharmaceutical drug with 49 clinical trials. Currently 6 active trials ongoing. Historical success rate of 91.2%.
Success Metrics
Based on 31 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
7
Mid Stage
23
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.2%
31 of 34 finished
8.8%
3 ended early
6
trials recruiting
49
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Clinical Trials (49)
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects
CHronic Nonbacterial Osteomyelitis International Registry
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Glutamate Inhibitors in Glioblastoma
Sulfasalazine in Patients With Metastatic Colorectal Cancer
Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
Treatments Against RA and Effect on FDG-PET/CT
Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 49